Clinical Trial Update: A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1 [Phase 2]

View source ↗

Summary

Phase 2B randomized trial evaluating UK-453,061 vs etravirine in combination therapy for antiretroviral-experienced HIV-1 with NNRTI resistance; trial terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• UK-453,061
• darunavir/ritonavir (darunavir/ritonavir)
• etravirine (etravirine)

Snippet

Sponsor: Pfizer | Conditions: HIV-1 | Phase 2 | Status: TERMINATED | Results posted: 2014-03-14